Skip to main content
OpenTrials
Completed

NCT Number: NCT00400166

Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

The purpose of this study is to determine whether Recovery Guide support services are effective in promoting recovery and social integration among psychiatrically disabled individuals who experience high rates of inpatient hospitalizations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Bipolar Disorder Bipolar and Related Disorders Mental Disorders Mood Disorders Psychotic Depression Psychotic Disorders Schizoaffective Disorder Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yale-New Haven Psychiatric Hospital

New Haven, Connecticut, 06519, United States

About this study

The paradigm shift in mental health treatment from a deficit-and institution- based framework to a recovery and community integration frame necessitates new models of "case management" practices. The Recovery Guide model is just such a model. Beyond theoretical frameworks, the effectiveness of Recovery Guides has not been well studied. It is the intent of this study to conduct a randomized trial examining the effects of Recovery Guides on community tenure and integration. Furthermore, it is the intent of this study to to establish fidelity criteria.

Comparison(s): Recovery Guide services in addition to treatment as usual, compared to treatment as usual.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Currently admitted in the Yale-New Haven Psychiatric Hospital (YNHPH)
  • A history of two or more prior admissions within the past 18 months
  • Proficient in the use of the English language
  • A DSM-IV diagnosis of Schizophrenia, Schizoaffective Disorder, Psychotic Disorder NOS, or Major Depressive Disorder with Psychotic Features

Exclusion criteria

  • Inability to give signed, written consent
  • Primary DSM-IV diagnosis of substance abuse/dependence

Treatment and study plan

Recovery Mentor

Behavioral

Provided Recovery Mentor services

Primary outcomes

  1. Number of hospitalizations

    Time frame: 9 months

Secondary outcomes

  1. Sense of community

    Time frame: Baseline, 3 and 9 months

  2. Motivation for change

    Time frame: Baseline, 3 and 9 months

  3. Social functioning

    Time frame: Baseline, 3 abd 9 months

  4. Hope

    Time frame: Baseline, 3 and 9 months

  5. Self-determination

    Time frame: Baseline, 3 and 9 months

  6. Functional status

    Time frame: Baseline, 3 and 9 months

  7. Treatment relationship

    Time frame: Baseline, 3 and 9 months

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Connecticut State, Department of Mental Health and Addiction Services
  • Eli Lilly and Company

Registry information

Important dates

Study start
2006
Primary completion
2009
Study completion
2009
First posted
Nov 16, 2006
Registry last updated
Jun 12, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.